Inhibition of Topoisomerase I Function by Coralyne and 5,6-Dihydrocoralyne
- 1 January 1996
- journal article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 9 (1) , 75-83
- https://doi.org/10.1021/tx950080y
Abstract
The antitumor agent coralyne and a number of structural analogues were found to be inhibitors of DNA topoisomerase I and were characterized biochemically. Several of these analogues stabilized the covalent binary complex formed between calf thymus topoisomerase I and pSP64 plasmid DNA; coralyne and 5,6-dihydrocoralyne had the greatest potency as inhibitors in this assay. In common with camptothecin, the effects of coralyne and 5,6-dihydrocoralyne were reversed in the presence of increasing salt concentration or temperature, consistent with the interpretation that both functioned mechanistically in a fashion analogous to camptothecin. The sequence specificity of DNA cleavage by coralyne and 5,6-dihydrocoralyne was also studied in comparison with camptothecin using a 471-bp DNA duplex as a substrate for topoisomerase I. Seven sites of cleavage were apparent, four of which were shared in common by coralyne, 5,6-dihydrocoralyne and camptothecin. Coralyne and 5,6-dihydrocoralyne produced cleavage at one sequence, 5'-TCTC decreases GTAA=3', that was not apparent in the presence of camptothecin; correspondingly, two cleavage bands appeared only when camptothecin was present. Coralyne and 5,6-dihydrocoralyne also inhibited topoisomerase I-mediated relaxation of supercoiled plasmid DNA. Coralyne was the most potent inhibitor of DNA relaxation; the effects of camptothecin and 5,6-dihydrocoralyne were roughly equal. At high concentrations, coralyne completely suppressed the formation of the topoisomerase I-DNA covalent binary complex.Keywords
This publication has 22 references indexed in Scilit:
- Synthesis and evaluation of new 6-amino- substituted benzo[c]phenanthridine derivativesJournal of Medicinal Chemistry, 1993
- The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and IIBiochemical Pharmacology, 1993
- UCE6, A new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from actinomycetes.The Journal of Antibiotics, 1993
- A Strategy for Identifying Novel, Mechanistically Unique Inhibitors of Topoisomerase IJournal of Natural Products, 1992
- Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activityJournal of Medicinal Chemistry, 1991
- Modification of the hydroxylactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activityJournal of Medicinal Chemistry, 1989
- Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavageJournal of Molecular Biology, 1988
- Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- DNA TopoisomerasesAnnual Review of Biochemistry, 1981
- DNA Modification and CancerAnnual Review of Biochemistry, 1981